Search
for
Sort by
Research 30 of 1000+
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Transmasculine Hormone Therapy
- Minoxidil
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Protective cardiovascular and renal actions of vitamin D and estrogen
- [Efficacy and cardiovascular tolerability of minotricon in the treatment of seborrheic alopecia].
- Comparative Analysis of Clinical Outcomes in Patients With Type 2 Diabetes Mellitus on Monotherapy Versus Combination Therapy
- Repurposing of approved cardiovascular drugs
- Androgenetic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Transsexualism
- Testosterone therapy for transgender men
- Management of polycystic ovarian syndrome through Homoeopathy: A Case Report
- Endocrinology of Transgender Medicine
- Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice
- Premature graying of hair
- Women’s Health Considerations for Lipid Management
- Supplementary file 1_Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis.docx
- Highlights
- Cardiovascular Toxicities of Androgen Deprivation Therapy
- Cardiovascular risk factors and events in women with androgen excess
- Somatic Outcomes and Nutritional Management of Anorexia Nervosa
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program